THE RELATIONSHIP BETWEEN SERUM INTACT PARATHYROID-HORMONE AND CALCIUMIN IDIOPATHIC HYPOPARATHYROIDISM

Citation
K. Mizunashi et al., THE RELATIONSHIP BETWEEN SERUM INTACT PARATHYROID-HORMONE AND CALCIUMIN IDIOPATHIC HYPOPARATHYROIDISM, Calcified tissue international, 53(6), 1993, pp. 378-383
Citations number
16
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0171967X
Volume
53
Issue
6
Year of publication
1993
Pages
378 - 383
Database
ISI
SICI code
0171-967X(1993)53:6<378:TRBSIP>2.0.ZU;2-9
Abstract
We studied the relationship between serum calcium (Ca) and parathyroid hormone (PTH) in patients with idiopathic hypoparathyroidism (IHP) to investigate the diversity of the degree of parathyroid insufficiency and a regulation of PTH secretion by Ca in IHP. Serum intact PTH conce ntrations ranged from < 1.0 to 10.3 pg/ml in 20 patients with IHP and were above the detection limit in 18 (90%) patients. Serum total Ca le vels in IHP were positively correlated with serum intact PTH (r = 0.82 4, P < 0.001), in contrast with a negative correlation between serum i ntact PTH and Ca in 91 normal subjects (r = -0.378, P < 0.001) and abn ormally high serum intact PTH values against hypocalcemia in five pati ents with pseudohypoparathyroidism. In three patients with IHP, serum intact PTH decreased in response to treatment with active vitamin D3 w hich increased serum Ca and 1,25(OH)2D. An inverse sigmoidal relations hip between serum ionized Ca and intact PTH was demonstrated in a pati ent with IHP before treatment [IHP(-)] and three patients with IHP tre ated with active vitamin D3[IHP(+)]. Peak serum intact PTH values were reduced in IHP(-) and IHP(+). Baseline serum intact PTH was 77.0% of the maximal level in IHP(-), 51.7-72.1% in IHP(+), and 31.1-42.3% in f ive normal subjects. The degree of parathyroid dysfunction in IHP diff ers from one patient to another and serum Ca levels are thought to be determined by circulating PTH levels. Although PTH secretory reserve i s diminished, PTH secretion is negatively regulated by Ca and is stimu lated at baseline in patients with IHP before and during the treatment with active vitamin D3.